Sunesis Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 13   

Articles published

SNSS 6.99 +0.20 (3.02%)
price chart
Sunesis Pharmaceuticals Inc.: Sunesis to Host Conference Call on August 5th to ...
SOUTH SAN FRANCISCO, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Tuesday, August 5, 2014 at 11:00 a.m.
Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 ...  MarketWatch
Related articles »  
Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance ...
SOUTH SAN FRANCISCO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Pediatric Committee of the European Medicines Agency (EMA) has issued a positive opinion on the Company's ...
Related articles »  
Melting Stocks- The Goodyear Tire & Rubber Company (GT), Sunesis ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) released the presentation of updated results from an ongoing Phase 1b/2 University of Texas MD Anderson Cancer Center-sponsored trial of Qinprezo(TM) (vosaroxin) in combination with decitabine in older ...
Related articles »  
Today's Watch List - Nokia Corporation (NYSE:NOK), Yelp (NYSE:YELP ...
Product Pipeline Review - 2014′, provides an overview of the Sunesis Pharmaceuticals, Inc.'s pharmaceutical research and development focus.
Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog
Late last week, Sunesis Pharmaceuticals, Inc. ( SNSS ) announced that the Pediatric Committee of the European Medicines Agency (EMA) accepted Sunesis' Pediatric Investigation Plan (PIP) for Qinprezo (vosaroxin) for first relapsed or refractory acute ...
Sunesis Pediatric Plan Accepted in the EU  Zacks.com
Related articles »  
Today's Stocks � International Business Machines (NYSE:IBM), Apple Inc ...
On July 14, Late last week, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced that the Pediatric Committee of the European Medicines Agency (EMA.